MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...
Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback